TRANSFORMING UROLOGY THERAPEUTICS

Botulinum Toxin A is highly efficacious in several bladder indications, including Overactive Bladder, Neurogenic Bladder, and Painful Bladder Syndrome. However, the toxin is currently injected into the bladder wall in an invasive procedure that involves side effects, pain and anesthesia.

Bladder cancer: in addition to toxin delivery, Vensica is also working to improve bladder cancer treatment with its proprietary platform.

Vensica developed a proprietary  minimally invasive, needle-free device to deliver botulinum toxin A to the bladder. Vensica’s procedure is very simple and quick both for the urologist and the patient. 

No needles, no anesthesia, and no cystoscopy required.

Overactive Bladder: Over 4 million patients fail oral medication treatment and seek a non-invasive solution to their illness.  

Neurogenic Bladder: Over 1.5 million patients do not respond positively to oral medication treatment and seek a non-invasive solution to their illness.  

Painful Bladder Syndrome: No effective treatment available for the 2 million patients in the USA.